Article | April 16, 2026

How To Select The Right Platform For Your Vaccine Manufacturing And Production Process

GettyImages-2024514092-vaccine-production-line-facility

Selecting the ideal adherent platform is a pivotal decision in vaccine development, where the choice between roller bottles, stacked vessels, and bioreactors directly impacts scalability and yield. To ensure project success, researchers must evaluate critical factors such as surface area requirements and the specific surface treatments necessary for optimal cell attachment. While traditional vessels may suffice for small-scale applications, transitioning to closed systems often becomes essential to mitigate contamination risks and reduce labor-intensive manual processes.

Effective process optimization begins with "starting with the end in mind," considering how early-stage decisions will translate to the terminal seed train. Small-scale process development testing serves as a vital safeguard, allowing teams to validate cell viability and adherence before committing to a full-scale manufacturing strategy. By balancing facility constraints with automation potential, labs can establish a more efficient path toward high-quality vaccine production. Dive into the full insights to refine your platform selection strategy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online